Nuclear Morphometry, Epigenetic Changes, and Clinical Relevance in Prostate Cancer

Nuclear structure alterations in cancer involve global genetic (mutations, amplifications, copy number variations, translocations, etc.) and epigenetic (DNA methylation and histone modifications) events that dramatically and dynamically spatially change chromatin, nuclear body, and chromosome organization. In prostate cancer (CaP) there appears to be early (<50 years) versus late (>60 years) onset clinically significant cancers, and we have yet to clearly understand the hereditary and somatic-based molecular pathways involved. We do know that once cancer is initiated, dedifferentiation of the prostate gland occurs with significant changes in nuclear structure driven by numerous genetic and epigenetic processes. This review focuses upon the nuclear architecture and epigenetic dynamics with potential translational clinically relevant applications to CaP. Further, the review correlates changes in the cancer-driven epigenetic process at the molecular level and correlates these alterations to nuclear morphological quantitative measurements. Finally, we address how we can best utilize this knowledge to improve the efficacy of personalized treatment of cancer.

[1]  W. Gerald,et al.  Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[2]  D. V. Von Hoff,et al.  5,6 Dihydro-5'-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells. , 1999, Anticancer research.

[3]  R Berezney,et al.  Identification of a nuclear protein matrix. , 1974, Biochemical and biophysical research communications.

[4]  Anant Madabhushi,et al.  Automated gland and nuclei segmentation for grading of prostate and breast cancer histopathology , 2008, 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[5]  Rajvir Dahiya,et al.  Epigenetic changes in prostate cancer: implication for diagnosis and treatment. , 2005, Journal of the National Cancer Institute.

[6]  Robert W Veltri,et al.  Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy , 2003, Cancer.

[7]  R. Dahiya,et al.  Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. , 2002, Journal of the National Cancer Institute.

[8]  D. Gleason,et al.  Histologic grading of prostate cancer: a perspective. , 1992, Human pathology.

[9]  T. Cremer,et al.  Chromosome territories. , 2010, Cold Spring Harbor perspectives in biology.

[10]  G. Crabtree,et al.  Understanding the Words of Chromatin Regulation , 2009, Cell.

[11]  George Lee,et al.  Multi-modal data fusion schemes for integrated classification of imaging and non-imaging biomedical data , 2011, 2011 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[12]  A. Partin,et al.  Quantitative Nuclear Grade , 2005 .

[13]  D. Tindall,et al.  p300 modulates nuclear morphology in prostate cancer. , 2005, Cancer research.

[14]  Martin J. Aryee,et al.  DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases , 2013, Science Translational Medicine.

[15]  Rachel E. Factor,et al.  The nuclear envelope environment and its cancer connections , 2012, Nature Reviews Cancer.

[16]  A. Otte,et al.  Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation , 1999, Nature Genetics.

[17]  Elizabeth Genega,et al.  Network cycle features: Application to computer-aided Gleason grading of prostate cancer histopathological images , 2011, 2011 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[18]  Ş. Özdamar,et al.  The relation between gleason score, and nuclear size and shape factors in prostatic adenocarcinoma , 2009, Turkish Journal of Medical Sciences.

[19]  S. Cross,et al.  The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells , 2008, The Prostate.

[20]  R W Veltri,et al.  Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei. , 1996, Urology.

[21]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[22]  D C Young,et al.  An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level. , 1996, The Journal of urology.

[23]  A W Partin,et al.  A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. , 1989, The Journal of urology.

[24]  Abena B. Redwood,et al.  Novel roles for A‐type lamins in telomere biology and the DNA damage response pathway , 2009, EMBO Journal.

[25]  U Aebi,et al.  Nuclear lamins: their structure, assembly, and interactions. , 1998, Journal of structural biology.

[26]  Mikhail Teverovskiy,et al.  Multifeature Prostate Cancer Diagnosis and Gleason Grading of Histological Images , 2007, IEEE Transactions on Medical Imaging.

[27]  Kaushik Sengupta,et al.  Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. , 2008, Genes & development.

[28]  J. Nickerson,et al.  Experimental observations of a nuclear matrix. , 2001, Journal of cell science.

[29]  D. S. Coffey,et al.  The use of multiparameter flow cytometry to assess tumor cell heterogeneity and grade prostate cancer , 1984, The Prostate.

[30]  K. Nakashiro,et al.  Androgen receptor expression in androgen‐independent prostate cancer cell lines , 2001, The Prostate.

[31]  R. Foisner,et al.  Lamin complexes in the nuclear interior control progenitor cell proliferation and tissue homeostasis , 2009, Cell cycle.

[32]  Papanicolaou Gn,et al.  The diagnostic value of vaginal smears in carcinoma of the uterus. 1941. , 1997 .

[33]  Thomas Cremer,et al.  Rise, fall and resurrection of chromosome territories: a historical perspective. Part I. The rise of chromosome territories. , 2006, European journal of histochemistry : EJH.

[34]  J. Epstein An update of the Gleason grading system. , 2010, The Journal of urology.

[35]  Robert W Veltri,et al.  Nuclear morphometry, nucleomics and prostate cancer progression. , 2012, Asian journal of andrology.

[36]  Robert W Veltri,et al.  Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge. , 2002, The Journal of urology.

[37]  Jonathan I. Epstein,et al.  Ability to Predict Metastasis Based On Pathology Findings and Alterations in Nuclear Structure Of Normal-Appearing and Cancer Peripheral Zone Epithelium in the Prostate , 2004, Clinical Cancer Research.

[38]  E. Meshorer,et al.  Nuclear lamins: key regulators of nuclear structure and activities , 2009, Journal of cellular and molecular medicine.

[39]  A. Partin,et al.  p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape , 2008, The Prostate.

[40]  D. Reinberg,et al.  Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. , 2001, Genes & development.

[41]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[42]  Po-Whei Huang,et al.  Automatic Classification for Pathological Prostate Images Based on Fractal Analysis , 2009, IEEE Transactions on Medical Imaging.

[43]  D. Tindall,et al.  The role of the androgen receptor in prostate cancer. , 2002, Critical reviews in eukaryotic gene expression.

[44]  A W Partin,et al.  Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections. , 1988, The Journal of urology.

[45]  Anant Madabhushi,et al.  A Boosted Bayesian Multiresolution Classifier for Prostate Cancer Detection From Digitized Needle Biopsies , 2012, IEEE Transactions on Biomedical Engineering.

[46]  Nicole Fruehauf,et al.  Theory And Practice Of Histotechnology , 2016 .

[47]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[48]  Claus Bahlmann,et al.  Computer-aided gleason grading of prostate cancer histopathological images using texton forests , 2010, 2010 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[49]  Christoph Wülfing,et al.  Polycomb Group Protein Ezh2 Controls Actin Polymerization and Cell Signaling , 2005, Cell.

[50]  D. S. Coffey Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions : commentary re: G. Brunagel et al., nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin. Cancer Res., 8: 3039-3045, 2002. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[52]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[53]  Dinggang Shen,et al.  Sampling the spatial patterns of cancer: Optimized biopsy procedures for estimating prostate cancer volume and Gleason Score , 2009, Medical Image Anal..

[54]  A. Feinberg,et al.  Higher order chromatin organization in cancer. , 2013, Seminars in cancer biology.

[55]  H. Klocker,et al.  Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway. , 2012, Carcinogenesis.

[56]  D. S. Coffey,et al.  Changing the energy habitat of the cancer cell in order to impact therapeutic resistance. , 2011, Molecular pharmaceutics.

[57]  B. Turner Environmental sensing by chromatin: An epigenetic contribution to evolutionary change , 2011, FEBS letters.

[58]  E. C. Schirmer,et al.  Cancer biology and the nuclear envelope: a convoluted relationship. , 2013, Seminars in cancer biology.

[59]  V. Pirrotta,et al.  Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites , 2002, Cell.

[60]  Anant Madabhushi,et al.  Adaptive Energy Selective Active Contour with Shape Priors for Nuclear Segmentation and Gleason Grading of Prostate Cancer , 2011, MICCAI.

[61]  R. Schoen,et al.  Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[62]  P. Nelson,et al.  Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. , 2011, Cancer cell.

[63]  M. van Lohuizen,et al.  Polycomb repression: from cellular memory to cellular proliferation and cancer. , 2002, Biochimica et biophysica acta.

[64]  D. S. Coffey,et al.  Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer , 1982, The Prostate.

[65]  S. Akopov,et al.  Structure and Functions of Nuclear Matrix Associated Regions (S/MARs) , 2004, Russian Journal of Bioorganic Chemistry.

[66]  S. Parodi,et al.  Differential expression of nuclear lamins in normal and cancerous prostate tissues. , 2006, Oncology reports.

[67]  P. V. van Diest,et al.  Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo , 2008, Molecular Cancer Therapeutics.

[68]  Peter J. Campbell,et al.  Evolution of the cancer genome , 2012, Nature Reviews Genetics.

[69]  R. Goldman,et al.  Nuclear lamins: building blocks of nuclear architecture. , 2002, Genes & development.

[70]  Gleason Df Classification of prostatic carcinomas. , 1966 .

[71]  R. Eeles,et al.  Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance , 2009, Prostate Cancer and Prostatic Diseases.

[72]  H. Klocker,et al.  Proteomics profiling of microdissected low- and high-grade prostate tumors identifies Lamin A as a discriminatory biomarker. , 2011, Journal of proteome research.

[73]  D. Ghosh,et al.  A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. , 2007, Cancer research.

[74]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.

[75]  M. Bustin,et al.  Regulation of chromatin structure and function by HMGN proteins. , 2010, Biochimica et biophysica acta.

[76]  J. Gill,et al.  Further observations on the chemistry of Pararosaniline-Feulgen staining , 1976, Histochemistry.

[77]  P. Maxwell,et al.  Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles , 2009, Journal of cellular and molecular medicine.

[78]  A. Chase,et al.  Aberrations of EZH2 in Cancer , 2011, Clinical Cancer Research.

[79]  A. Imbalzano,et al.  Nuclear Shape Changes Are Induced by Knockdown of the SWI/SNF ATPase BRG1 and Are Independent of Cytoskeletal Connections , 2013, PloS one.

[80]  J. Lawrence,et al.  Changing nuclear landscape and unique PML structures during early epigenetic transitions of human embryonic stem cells , 2009, Journal of cellular biochemistry.

[81]  J. Bridger,et al.  Exploring the effects of a dysfunctional nuclear matrix. , 2008, Biochemical Society transactions.

[82]  Anil K. Jain,et al.  Automated Gland Segmentation and Classification for Gleason Grading of Prostate Tissue Images , 2010, 2010 20th International Conference on Pattern Recognition.

[83]  D. Gilbert,et al.  Actin up in the nucleus , 2004, Nature Reviews Molecular Cell Biology.

[84]  Zhen Zhang,et al.  Cardinal Multiridgelet-based Prostate Cancer Histological Image Classification for Gleason Grading , 2011, 2011 IEEE International Conference on Bioinformatics and Biomedicine.

[85]  A. Sasseville,et al.  Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. , 1995, Journal of cell science.

[86]  Qiang Yu,et al.  Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. , 2007, Genes & development.

[87]  S. Przyborski,et al.  Lamins as cancer biomarkers. , 2010, Biochemical Society transactions.

[88]  M. Lohuizen,et al.  The Polycomb group--no longer an exclusive club? , 2001, Current opinion in genetics & development.

[89]  Michael Q. Zhang,et al.  Combinatorial patterns of histone acetylations and methylations in the human genome , 2008, Nature Genetics.

[90]  A W Partin,et al.  Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. I. Testing of a digitization system. , 1988, The Journal of urology.

[91]  M. Cohen,et al.  Classics in cytology VI: The early cytologic discoveries of Lionel S. Beale , 1993, Diagnostic cytopathology.

[92]  Ming Gao,et al.  Computer-aided prostrate cancer diagnosis using image enhancement and JPEG2000 , 2003, SPIE Optics + Photonics.

[93]  J. Herman,et al.  Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. , 1998, Cancer research.

[94]  A. Schetter,et al.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. , 2010, Carcinogenesis.

[95]  R. Virchow,et al.  Cellular Pathology, as Based upon Physiological and Pathological Histology , 1860, Nutrition reviews.

[96]  T. Tammela,et al.  EZH2, Ki‐67 and MCM7 are prognostic markers in prostatectomy treated patients , 2008, International journal of cancer.

[97]  D. S. Coffey,et al.  The application of perpendicular and forward light scatter to assess nuclear and cellular morphology. , 1984, Cytometry.

[98]  Anant Madabhushi,et al.  AUTOMATED GRADING OF PROSTATE CANCER USING ARCHITECTURAL AND TEXTURAL IMAGE FEATURES , 2007, 2007 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[99]  Shihua He,et al.  Chromatin organization and nuclear microenvironments in cancer cells , 2008, Journal of cellular biochemistry.

[100]  Th. Boveri Concerning the Origin of Malignant Tumours by Theodor Boveri. Translated and annotated by Henry Harris , 2008, Journal of Cell Science.

[101]  A. Partin,et al.  SELDI protein profiling of dunning R‐3327 derived cell lines: Identification of molecular markers of prostate cancer progression , 2007, The Prostate.

[102]  André Huisman,et al.  Discrimination between benign and malignant prostate tissue using chromatin texture analysis in 3‐D by confocal laser scanning microscopy , 2007, The Prostate.

[103]  Robert W Veltri,et al.  Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow‐up after radical prostatectomy , 2010, The Prostate.

[104]  J. Broers,et al.  The nuclear envelope, a key structure in cellular integrity and gene expression. , 2007, Current medicinal chemistry.

[105]  Edison T. Liu,et al.  Regulation of Transcription through Acetylation of H3K122 on the Lateral Surface of the Histone Octamer , 2013, Cell.

[106]  George Lee,et al.  Computer-aided prognosis: Predicting patient and disease outcome via quantitative fusion of multi-scale, multi-modal data , 2011, Comput. Medical Imaging Graph..

[107]  D. Wittekind,et al.  Standardization of the Feulgen-Schiff technique , 2004, Histochemistry.

[108]  Lars Egevad,et al.  Contemporary Grading for Prostate Cancer: Implications for Patient Care ☆ , 2013 .